A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients-Reference-Cited by-同舟云学术

A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients

Published:2022-04-23 Issue: Volume: Page:
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Winkle Peter,Goldsmith Steven,Koren Michael J.,Lepage Serge,Hellawell Jennifer,Trivedi Ashit,Tsirtsonis Kate,Abbasi Siddique A.,Kaufman Allegra,Troughton Richard,Voors Adriaan,Hulot Jean-Sebastien,Donal Erwan,Kazemi Navid,Neutel Joel

Funder

amgen

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-022-07328-w.pdf

Reference40 articles.

1. Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from theAmerican Heart Association. Circulation. 2020. https://doi.org/10.1161/cir.0000000000000757.

2. Armstrong PW, Pieske B, Anstrom KJ, et al. Vericiguat in patients with heart failure with reduced ejection fraction. N Engl J Med. 2020. https://doi.org/10.1056/nejmoa1915928.

3. Cleland JG, Daubert J-C, Erdmann E, et al. The effectof cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005. https://doi.org/10.1056/nejmoa050496.

4. Krum H, Teerlink JR. Medical therapy for chronic heart failure. Lancet. 2011. https://doi.org/10.1016/s0140-6736(11)61038-6.

5. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019. https://doi.org/10.1056/nejmoa1911303.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular insights of exercise therapy in disease prevention and treatment;Signal Transduction and Targeted Therapy;2024-05-29

2. Expression of the apelin receptor, a novel potential therapeutic target, and its endogenous ligands in diverse stem cell populations in human glioblastoma;Frontiers in Neuroscience;2024-05-13

3. Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptor;2024-04-04

4. Localized apelin-17 analogue-bicelle interactions as a facilitator of membrane-catalyzed receptor recognition and binding;Biochimica et Biophysica Acta (BBA) - Biomembranes;2024-03

5. Targeting the apelin system for the treatment of cardiovascular diseases;Cardiovascular Research;2023-11-13